Reuters: Money News: Wockhardt to appoint consultant at plant for U.S. FDA compliance

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Wockhardt to appoint consultant at plant for U.S. FDA compliance Jul 25th 2013, 06:32 MUMBAI (Reuters) - Wockhardt has initiated a process to appoint a U.S.-based consultant at its western India drug factory, its managing director said, after the U.S. drug regulator issued a warning letter to the factory over quality compliance issues.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions